Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks

Khan, Shahid; Panicker, Jalesh; Roosen, Alexander; Gonzales, Gwen; Elneil, Sohier; Dasgupta, Prokar; Fowler, Clare J; Kessler, Thomas M (2010). Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks. European urology, 57(5), pp. 891-6. Amsterdam: Elsevier 10.1016/j.eururo.2009.04.020

Full text not available from this repository. (Request a copy)

Objective improvement following intradetrusor injections of botulinum neurotoxin type A (BoNTA) is well documented. Although patient-related outcome measures are highly recommended for monitoring overactive bladder symptoms, no study before has dealt with the question of patient-reported complete continence after BoNTA treatment using validated questionnaires.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Kessler, Thomas M.

ISSN:

0302-2838

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:07

Last Modified:

04 May 2014 23:04

Publisher DOI:

10.1016/j.eururo.2009.04.020

PubMed ID:

19394133

Web of Science ID:

000275739600029

URI:

https://boris.unibe.ch/id/eprint/191 (FactScience: 196745)

Actions (login required)

Edit item Edit item
Provide Feedback